India, July 16 -- India's pharmaceutical exports to the United Kingdom are expected to grow by more than 8% to reach nearly USD 981 million in FY27, following the implementation of the India-UK Free Trade Agreement (FTA), according to the Pharmaceuticals Export Promotion Council of India (Pharmexcil). The trade pact is expected to improve market access, reduce trade barriers and strengthen the competitiveness of Indian medicines in the UK market.

Pharmexcil said the agreement will provide a major boost to India's generic drug manufacturers by offering duty-free access and creating new opportunities for pharmaceutical exports. The council also expects stronger collaboration between Indian and British companies in research, innovation and ...